Shin, Thomas H.
Rosinski, Bradley
Strong, Andrew
Fayazzadeh, Hana
Fathalizadeh, Alisan
Rodriguez, John
El-Hayek, Kevin
Article History
Received: 3 September 2021
Accepted: 14 November 2021
First Online: 22 November 2021
Declarations
:
: The authors have the following disclosures: Kevin El-Hayek, MD—Consultant for the Takeda Clinical Advisory Board; Thomas H. Shin, MD, PhD, Bradley Rosinski, MD, Andrew Strong, MD, Hana Fayazzadeh, MD, Alisan Fathalizadeh, MD and John Rodriguez, MD have no conflict of interest or financial ties to disclose.